DocGo Inc. Capital Expenditures
DocGo Inc. (DCGO) reported Capital Expenditures of $751.14 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-17
- DocGo Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $320.83K, a 71.89% decline year-over-year.
- DocGo Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $430.31K, a 58.21% decline year-over-year.
- DocGo Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.50M, a 106.55% increase year-over-year.
- DocGo Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $876.18K, a 2.88% decline year-over-year.
- DocGo Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $4.54M, a 25.79% increase from fiscal 2024.
- DocGo Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $3.61M, a 50.60% decline from fiscal 2023.
- DocGo Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $7.31M, a 128.67% increase from fiscal 2022.
- DocGo Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.20M, a 33.49% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $320.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $751.14K 10-Q · filed 2026-08-17 | $2.25M derived: sum of 3 quarters · filed 2026-08-17 | $3.12M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2026-03-31 | $430.31K 10-Q · filed 2026-05-11 | $1.93M derived: sum of 2 quarters · filed 2026-05-11 | $2.80M derived: sum of 3 quarters · filed 2026-05-11 | $3.94M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.37M derived: sum of 2 quarters · filed 2026-03-16 | $3.51M derived: sum of 3 quarters · filed 2026-08-17 | $4.54M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $876.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.02M derived: sum of 2 quarters · filed 2026-08-17 | $3.05M 10-Q · filed 2025-11-10 | $3.77M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $2.17M 10-Q · filed 2026-08-17 | $2.90M derived: sum of 3 quarters · filed 2026-08-17 | $3.80M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-03-31 | $1.03M 10-Q · filed 2026-05-11 | $1.47M 10-Q · filed 2025-05-08 | $1.75M derived: sum of 2 quarters · filed 2026-05-11 | $2.66M derived: sum of 3 quarters · filed 2026-05-11 | $3.69M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $724.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.63M derived: sum of 2 quarters · filed 2026-03-16 | $2.66M derived: sum of 3 quarters · filed 2026-03-16 | $3.61M 10-K · filed 2026-03-16 | $3.83M 10-K · filed 2025-02-27 | |||
| 2024-09-30 | $902.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.94M derived: sum of 2 quarters · filed 2025-11-10 | $2.89M 10-Q · filed 2025-11-10 | $2.94M 10-Q · filed 2024-11-07 | $5.84M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.99M 10-Q · filed 2025-08-07 | $2.15M 10-Q · filed 2024-08-07 | $4.94M derived: sum of 3 quarters · filed 2026-03-16 | $5.74M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-03-31 | $951.70K 10-Q · filed 2025-05-08 | $3.90M derived: sum of 2 quarters · filed 2026-03-16 | $4.71M derived: sum of 3 quarters · filed 2026-03-16 | $6.29M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.75M derived: sum of 2 quarters · filed 2026-03-16 | $5.34M derived: sum of 3 quarters · filed 2026-03-16 | $7.31M 10-K · filed 2026-03-16 | $7.58M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $801.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.38M derived: sum of 2 quarters · filed 2024-11-07 | $4.36M 10-Q · filed 2024-11-07 | $5.56M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.56M 10-Q · filed 2024-08-07 | $4.76M derived: sum of 3 quarters · filed 2025-02-27 | $5.82M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $1.98M 10-Q · filed 2024-05-08 | $3.18M derived: sum of 2 quarters · filed 2025-02-27 | $4.23M derived: sum of 3 quarters · filed 2025-02-27 | $4.57M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.26M derived: sum of 2 quarters · filed 2025-02-27 | $2.60M derived: sum of 3 quarters · filed 2025-02-27 | $3.20M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.39M derived: sum of 2 quarters · filed 2023-11-06 | $1.99M 10-Q · filed 2023-11-06 | $3.98M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $339.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $941.65K 10-Q · filed 2023-08-08 | $2.93M derived: sum of 3 quarters · filed 2024-02-28 | $3.17M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $602.42K 10-Q · filed 2023-05-09 | $2.59M derived: sum of 2 quarters · filed 2024-02-28 | $2.83M derived: sum of 3 quarters · filed 2024-02-28 | $4.65M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.23M derived: sum of 2 quarters · filed 2024-02-28 | $4.05M derived: sum of 3 quarters · filed 2024-02-28 | $4.81M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $243.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.06M derived: sum of 2 quarters · filed 2022-11-08 | $2.82M 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.58M 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | $760.05K 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | $4.36M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |